GT Biopharma, Inc.·4

Sep 8, 5:45 PM ET

CASAMENTO CHARLES J 4

4 · GT Biopharma, Inc. · Filed Sep 8, 2025

Insider Transaction Report

Form 4
Period: 2025-09-04
Transactions
  • Award

    Option to purchase Common Stock

    2025-09-04+62,50062,500 total
    Exercise: $1.33Exp: 2035-08-19Common Stock (62,500 underlying)
Footnotes (1)
  • [F1]The options are fully vested and exercisable.

Documents

1 file
  • 4
    ownership.xmlPrimary